PGEN Stock Analysis: Buy, Sell, or Hold?
PGEN - Precigen, Inc. Common Stock
$5.12
-0.05 (-0.97%)
▼
5d:
-7.08%
30d:
+13.02%
90d:
+22.78%
HOLD
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 11, 2026
26d
Smart Money Accumulation
None View Scanner →
Strength: 8.0/10
Get Alerted When PGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PGEN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PGEN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGEN is currently trading at $5.12, which is considered fair relative to its 30-day fair value range of $4.34 to $5.71. From a valuation perspective, the stock is trading at a discount (Forward PE: 25.6) compared to its historical average (46.2). Remarkably, the market is currently pricing in an annual earnings decline of 17.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PGEN is in a strong uptrend. The price is currently testing key support at $5.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.45 (+143.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGEN is in a strong uptrend. The price is currently testing key support at $5.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.45 (+143.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.34 -
$5.71
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
Protect Your Profits
Holding PGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 143.2% below Wall St target ($12.45)
- CAUTION: Recommendation downgraded due to -7.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$4.34 -
$5.71
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.00
Resistance Level
$5.97
Current Trend
Strong Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.60
Wall Street Target
$12.45
(+143.2%)
Revenue Growth (YoY)
1633.9%
Valuation Discount vs History
-17.8% cheaper
PE vs Historical
25.6 vs 46.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.8%
(market-implied from PE analysis)
1-Year Target
$4.61
(-10%)
2-Year Target
$4.15
(-19%)
3-Year Target
$3.73
(-27%)
3-Yr Target (if PE normalizes)
(PE: 26→46)
$6.74
(+32%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.6 to 46.2
Stabilization Target:
$9.24
(+80.5%)
PE Expansion Potential:
+80.5%
Share & Embed Analysis
Last updated: July 14, 2026 8:08 PM ET
Data refreshes hourly during market hours. Next update: 9:08 PM
Data refreshes hourly during market hours. Next update: 9:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Randal J Kirk
SELL
4772781 shares
2026-03-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 55 HOLD |
Advanced PGEN Option Strategies
Professional options setups generated by AI based on today's PGEN price and gamma walls.
